550-CAR-T Reprogram Macrophage Tumor Microenvironment

This research explores a novel CAR-T cell therapy designed to treat solid tumors by targeting the tumor microenvironment rather than cancer cells directly. Scientists engineered armored CAR-T cells to deplete immunosuppressive macrophages—specifically those expressing FOLR2 or TREM2—while simultaneously delivering the potent immune stimulant IL-12. In animal models of ovarian, pancreatic, and lung...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动